NCT06415019View on ClinicalTrials.gov

A Study to Learn About Whether BAY H006689 Causes an Allergic Reaction When Applied as a Topical Gel in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

June 5, 2024

Primary Completion Date

August 1, 2024

Study Completion Date

August 1, 2024

Conditions
PainHealthy Volunteers
Interventions
DRUG

Naproxen (BAYH006689)

BAYH006689 gel will be dispensed directly on the patch

DRUG

Placebo Gel

Placebo gel will be dispensed directly on the patch

DRUG

A solution of 0.9% Saline

0.9% Saline will be dispensed directly on the patch.

Trial Locations (1)

07410

TKL Research, Inc., Fair Lawn

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT06415019 - A Study to Learn About Whether BAY H006689 Causes an Allergic Reaction When Applied as a Topical Gel in Healthy Participants | Biotech Hunter | Biotech Hunter